Healthcare innovation

There’s no shortage of innovation in healthcare because there is no shortage of challenges. The COVID-19 pandemic spotlights existing strains on healthcare systems around the world. The capacity of these systems was already stretched, with long patient wait times, costly emergency room visits and a lengthy drug development process. 

On top of these challenges is the fact that healthcare costs in the United States are exorbitant, with heart disease, cancer and diabetes as the top contributors. At the same time, rare diseases affect over 25 million people in the United States and 400 million worldwide. About half of all rare diseases affect children.

The good news is that scientists, technologists and biotech companies are collaborating and innovating to address—even potentially solve—these longstanding challenges in newer and faster ways than before. The combination of an abundance of healthcare data and gene-based technologies is accelerating innovation, leading to breakthrough results and creating compelling opportunities.


Explore additional key investment themes and megatrends such as digital transformation and sustainability.